Home / Business and Economy / Gaudium IVF IPO Opens Strong, Surging 0.90 Times
Gaudium IVF IPO Opens Strong, Surging 0.90 Times
20 Feb
Summary
- Gaudium IVF's IPO opened on February 20, 2026, subscribed 0.90 times.
- The company aims to raise ₹165 crore for expansion and launching new products.
- Shares are priced between ₹75-79, with listing expected February 27, 2026.
Gaudium IVF and Women Health's initial public offering (IPO) commenced on February 20, 2026, drawing considerable investor attention. By the end of the first day, the issue was subscribed 0.90 times, with bids received for 1.27 crore shares against the 1.46 crore shares offered.
The IPO aims to raise ₹165 crore, primarily for expansion initiatives. These include setting up new IVF centers, investing in its subsidiary EKK Global Pvt Ltd, and developing new FMCG products. A portion of the funds will also support working capital and general corporate needs.
Dr. Manika Khanna, the promoter and founder, currently holds a 99.32% stake and will see her shareholding reduce to 70.73% post-IPO. The shares are being offered at a price band of ₹75 to ₹79. The allotment is expected on February 25, 2026, with the IPO scheduled to list on the BSE and NSE on February 27, 2026.
Early indications from the grey market premium (GMP) suggest a potential listing price of ₹87.5 per share, indicating a possible gain of 10.7% above the upper price band. Sarthi Capital Advisors Pvt Ltd and Bigshare Services Pvt Ltd are managing the issue as lead manager and registrar, respectively.
